Tapros Tablet (Talinopride)

Adult dose

Administer 370 mg of talniflumate orally 3 times daily. For severe cases, administer 740 mg per dose. Adjust the dose as appropriate according to age and symptoms.

People who regularly consume more than three glasses of alcohol per day must consult with a physician or pharmacist before taking this medication. This is because gastrointestinal bleeding may occur as a result of taking this medication. This medication may increase the risk of cardiovascular disease. There is a possibility of serious cardiovascular issues such as myocardial infarction or stroke, so patients with cardiovascular disease or risk factors should exercise particular caution. Doctors and patients must observe carefully for the appearance of cardiovascular symptoms, and if symptoms occur, immediate action must be taken. This medication may increase the risk of serious gastrointestinal adverse reactions such as gastrointestinal bleeding, ulcers, and perforations. Particularly elderly patients or those with a history of gastrointestinal disease should be extra careful, and immediate evaluation and treatment are needed if gastrointestinal symptoms arise. Patients with a history of peptic ulcer or an allergy to this medication or its components, or who have allergic reactions to aspirin or other non-steroidal anti-inflammatory drugs, should not take this medication. Patients with severe liver, kidney, or heart disease, pregnant women, or women of childbearing potential should also avoid taking this medication. Patients with mild to moderate liver, kidney, or heart disease, elderly individuals, and those on diuretics should take this medication cautiously and monitor their condition closely. This medication can cause various adverse reactions, including gastrointestinal symptoms such as nausea, vomiting, diarrhea, as well as rare instances of skin rash, asthma attacks, hypotension, heart issues, and kidney function abnormalities. When used long-term, regular blood tests and liver and kidney function tests should be conducted, and if abnormal symptoms appear, consultation with a doctor should be immediate. This medication is preferably not taken in conjunction with other anti-inflammatory drugs, and because it may interact with certain medications, it is essential to inform healthcare providers of any other medications being taken. Pregnant women, particularly in the later stages of pregnancy, should not take this medication due to potential risks to the fetus, and breastfeeding mothers should consider discontinuing breastfeeding or the medication due to potential risks of drug transfer through breast milk to the infant. Children, especially those under 12 years old, should not be administered this medication. Elderly patients should be administered the minimum dosage cautiously and their adverse reactions should be monitored carefully. This medication must be stored in a safe place out of the reach of children, and it should not be transferred to another container.

• Gastrointestinal hemorrhage
• cardiovascular thrombotic reactions
• myocardial infarction
• stroke
• nausea
• vomiting
• photosensitivity
• asthma attacks
• systemic weakness due to hypotension
• hypersensitivity shock

This medication should be stored in a tightly sealed container to prevent air or moisture infiltration, and the storage temperature should be maintained at room temperature, avoiding extreme heat or cold. This will help to preserve the efficacy of the medication for a longer period.

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle